TNF and rheumatoid arthritis: Tumor necrosis factor-alpha (TNF-alpha) inhibitors and Janus Kinase (JAK) inhibitors fall into two distinct categories of Disease-modifying anti-rheumatic drugs (DMARDs) frequently utilized in the management of RA [83, 84].